Given IBA1 levels are implicated in microglial phagocytosis, which plays a central role for removing Aβs from the brain [12–14, 50], we examined whether IBA1 immunodensity correlated with levels of the insoluble (plaque-associate) and soluble forms of Aβs in our AD brain samples. This evidence concerns the gene AIF1 and Alzheimer disease.